2018
DOI: 10.3389/fmicb.2018.01159
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Potential of a Scorpion Venom-Derived Antimicrobial Peptide and Its Homologs Against Antibiotic-Resistant Gram-Positive Bacteria

Abstract: The alarming rise in the prevalence of antibiotic resistance among pathogenic bacteria poses a unique challenge for the development of effective therapeutic agents. Antimicrobial peptides (AMPs) have attracted a great deal of attention as a possible solution to the increasing problem of antibiotic-resistant bacteria. Marcin-18 was identified from the scorpion Mesobuthus martensii at both DNA and protein levels. The genomic sequence revealed that the marcin-18 coding gene contains a phase-I intron with a GT-AG … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
24
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 40 publications
(24 citation statements)
references
References 46 publications
(53 reference statements)
0
24
0
Order By: Relevance
“…There is also emerging evidence of their efficacy in vivo. One recent example demonstrated the recovery of mice from a lethal bacteraemia caused by clinical methicillin-resistant Staphylococcus aureus through the administration of an AMP derived from scorpion venom [67]. However, challenges also remain with respect to the biostability and bioavailability of these AMPs such that some form of physicochemical optimisation (i.e., PEGylation, peptide cyclisation) are often required, particularly when considering using routes of administration other than parenteral for peptides [68,69].…”
Section: Pain Therapeutics and Congenital Neurological Conditionsmentioning
confidence: 99%
“…There is also emerging evidence of their efficacy in vivo. One recent example demonstrated the recovery of mice from a lethal bacteraemia caused by clinical methicillin-resistant Staphylococcus aureus through the administration of an AMP derived from scorpion venom [67]. However, challenges also remain with respect to the biostability and bioavailability of these AMPs such that some form of physicochemical optimisation (i.e., PEGylation, peptide cyclisation) are often required, particularly when considering using routes of administration other than parenteral for peptides [68,69].…”
Section: Pain Therapeutics and Congenital Neurological Conditionsmentioning
confidence: 99%
“…As the global antimicrobial resistance (AMR) crisis continues and exacerbates, the scientific community are engaged in not only trying to discover novel antimicrobials to treat antimicrobial‐resistant infections (Choi, Hwang, & Lee, 2014; Liu, Yang, et al, 2018) but also understand the drivers of resistance and potential reservoirs of resistant pathogens (Kotsanas et al, 2013; Li et al, 2018; Lowe et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…Venoms produced by different species, such as scorpions, snakes, and spiders, are used as protection or to capture prey. Various peptides found in venom produced by scorpions have been reported to have broad-spectrum antimicrobial, anticancer, and anti-inflammatory activities [ 12 , 13 ]. Numerous scorpion venom antimicrobial peptides (AMPs) have been reported as various therapeutic agents because of their low resistance rate [ 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%